Overview
Background
Dr Zachary Hawula is a postdoctoral research fellow in the Lymphoma Research Lab at the Frazer Institute located within the Translational Research Institute in Brisbane. Having completed his Doctor of Philosophy at the University of Queensland in 2021 investigating genetic and chemical modulators of iron metabolism, haemochromatosis and anaemia. After Completing his PhD, Zach research interests changed to developing novel cell lines using CRISPR/Cas9 prime editing which mimic the rare inherited condition Wilson's Disease. A copper overolad disorder causes copper levels to build up in several organs, especially the liver, brain and eyes. Since begining his role in the Lymphoma Research Lab in 2022, Zachary is now focused on using cutting edge technologies such as single cell RNAseq (scRNAseq) to understand rare B cell lymphomas primarily focusing on Primary Central Nervous System Lymphoma (PCNSL) and Secondary CNS Lymphoma.
Availability
- Dr Zachary Hawula is:
- Not available for supervision
Research interests
-
Tumour Immunology
-
Primary CNS Lymphoma
-
DLBCL
Works
Search Professor Zachary Hawula’s works on UQ eSpace
2025
Conference Publication
Distinct immune checkpoint landscapes in PCNSL and SCNSL revealed by single-nucleus profiling
Hawula, Zachary, Tuczko, Nella, Burgess, Melinda, Bradbury, Lucy, Chowdhury, Rakin, Swain, Fiona, Hawkes, Eliza, Wight, Joel and Keane, Colm (2025). Distinct immune checkpoint landscapes in PCNSL and SCNSL revealed by single-nucleus profiling. 67th ASH Annual Meeting, New Orleans, LA, United States, 12-15 December, 2025. New York, NY, United States: Elsevier. doi: 10.1182/blood-2025-149
2025
Conference Publication
Divergent immune programs in EBV⁺ PCNSL: a multiomic study of AR-PCNSL and cns-PTLD
Burgess, Melinda, Hawula, Zachary, Kempe, Sarah, Murigneux, Valentine, Swain, Fiona, Chowdhury, Rakin, Tuczko, Nella, Bradbury, Lucy, Antczak, Magdalena, Mehdi, Ahmed, Hawkes, Eliza, Wight, Joel, Gould, Clare, Gandhi, Maher, Jiang, Sizun, Maguire, Alanna and Keane, Colm (2025). Divergent immune programs in EBV⁺ PCNSL: a multiomic study of AR-PCNSL and cns-PTLD. 67th ASH Annual Meeting, Orlando, FL USA, 6-9 December 2025. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2025-457
2025
Conference Publication
Multiomic dissection of immune-privileged DLBCL reveals divergent immune subtypes in testicular and primary central nervous system lymphoma
Burgess, Melinda, Hawula, Zachary, Tuczko, Nella, Kempe, Sarah, Murigneux, Valentine, Swain, Fiona, Chowdhury, Rakin, Bradbury, Lucy, Antczak, Magdalena, Mehdi, Ahmed, Hawkes, Eliza, Wight, Joel, Henden, Andrea, Sheehy, Joshua, Gandhi, Maher, Jiang, Sizun and Keane, Colm (2025). Multiomic dissection of immune-privileged DLBCL reveals divergent immune subtypes in testicular and primary central nervous system lymphoma. 67th ASH Annual Meeting and Exposition, Orlando, FL, United States, 6-9 December 2025. Washington, DC, United States: American Society of Hematology. doi: 10.1182/blood-2025-147
2024
Conference Publication
Biological Features of Response to Immune Checkpoint Inhibitor and Rituximab Priming in Diffuse Large B-Cell Lymphoma
Chowdhury, Rakin, Manos, Kate, Burgess, Melinda, Chong, Geoffrey, Lee, Sze-Ting, Hawula, Zachary, Tuczko, Nella, Smith, Charmaine, Fancourt, Tineke, Churilov, Leonid, Scott, Andrew, Barraclough, Allison, Wight, Joel, McKendrick, Joe, Lin, Wendi, Swain, Fiona, Hawkes, Eliza A. and Keane, Colm (2024). Biological Features of Response to Immune Checkpoint Inhibitor and Rituximab Priming in Diffuse Large B-Cell Lymphoma. 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-201230
2024
Conference Publication
Multiomics Analysis of Paired Diagnosis and Relapse DLBCL Biopsies Shows a Reduction in T Cell Infiltration and Function at Relapse
Swain, Fiona, Burgess, Melinda, Kempe, Sarah, Sabdia, Muhammed B., Henden, Andrea S., Wight, Joel, Hawkes, Eliza A., Mutsando, Howard, Talaulikar, Dipti, Merida de Long, Lilia, Birch, Simone, Wyche, Penelope, Hawula, Zachary, Chowdhury, Rakin, Gandhi, Maher K. and Keane, Colm (2024). Multiomics Analysis of Paired Diagnosis and Relapse DLBCL Biopsies Shows a Reduction in T Cell Infiltration and Function at Relapse. 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-199352
2023
Conference Publication
Gene expression and spatial transcriptomic analysis of paired diagnosis and relapse DLBCL biopsies show a reduction in T cell infiltration and function at relapse
Swain, F., Burgess, M., Kempe, S., Sabdia, M., Wight, J., Hawkes, E., Mutsando, H., Talaulikar, D., Merida de Long, L., Hawula, Z., Birch, S., Wyche, P., Gandhi, M. K. and Keane, C. (2023). Gene expression and spatial transcriptomic analysis of paired diagnosis and relapse DLBCL biopsies show a reduction in T cell infiltration and function at relapse. 17th International Conference on Malignant Lymphoma, Lugano, Switzerland, 13 - 17 June 2023. Chichester, West Sussex United Kingdom: Wiley-Blackwell. doi: 10.1002/hon.3164_191
2021
Journal Article
In vitro identification and characterisation of iron chelating catechol-containing natural products and derivatives
Hawula, Zachary J., Davis, Rohan A., Wallace, Daniel F., Rishi, Gautam and Subramaniam, V. Nathan (2021). In vitro identification and characterisation of iron chelating catechol-containing natural products and derivatives. BioMetals, 34 (4), 855-866. doi: 10.1007/s10534-021-00312-1
2021
Journal Article
The effect of the flavonol rutin on serum and liver iron content in a genetic mouse model of iron overload
Hawula, Zachary J., Secondes, Eriza S., Wallace, Daniel F., Rishi, Gautam and Subramaniam, V. Nathan (2021). The effect of the flavonol rutin on serum and liver iron content in a genetic mouse model of iron overload. Bioscience Reports, 41 (7) BSR20210720. doi: 10.1042/BSR20210720
2019
Journal Article
Therapeutic advances in regulating the hepcidin/ferroportin axis
Hawula, Zachary J., Wallace, Daniel F., Subramaniam, V. Nathan and Rishi, Gautam (2019). Therapeutic advances in regulating the hepcidin/ferroportin axis. Pharmaceuticals, 12 (4) 170, 170. doi: 10.3390/ph12040170
Supervision
Availability
- Dr Zachary Hawula is:
- Not available for supervision
Supervision history
Current supervision
-
Doctor Philosophy
Investigation of responses to CAR-T cell therapy in PCNSL
Associate Advisor
Other advisors: Associate Professor Colm Keane
-
Doctor Philosophy
Immuno-genetic biomarkers of response in a prospective study of immune checkpoint therapy in primary CNS lymphoma
Associate Advisor
Other advisors: Associate Professor Arutha Kulasinghe, Associate Professor Colm Keane
-
Doctor Philosophy
Investigating the mechanisms of immune evasion in relapsed/refractory DLBCL
Associate Advisor
Other advisors: Associate Professor Colm Keane
Media
Enquiries
For media enquiries about Dr Zachary Hawula's areas of expertise, story ideas and help finding experts, contact our Media team: